Biotech

All Articles

Enanta's RSV antiviral crushes virus-like lots in challenge research

.Enanta Pharmaceuticals has connected its breathing syncytial virus (RSV) antiviral to substantial d...

Biogen containers SAGE-324 collaboration after vital shake neglect

.Biogen has actually provided the final rites to its own partnership along with Sage Therapies on SA...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel purchase credit ratings

.On the same time that some Parkinson's illness medicines are actually being actually disputed, AbbV...

Arch closes $3B-plus fund to nurture biopharma startups

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arch Project Allies is ac...

Orion to make use of Aitia's 'digital identical twins' to discover new cancer cells drugs

.Finnish biotech Orion has snooped prospective in Aitia's "digital twin" technician to establish bra...

Windtree's surprise med brings up blood pressure in most recent phase 2 win

.While Windtree Therapeutics has actually strained to grow the financial roots needed to endure, a p...

2 cancer cells biotechs combine, making international footprint

.OncoC4 is taking AcroImmune-- and its own in-house professional manufacturing abilities-- under its...

Amgen records very first phase 3 win for $400M chronic eczema medicine

.Amgen has actually shared (PDF) the initial period 3 records on its own $400 million dermatitis med...

Biogen, UCB file period 3 lupus gain after stopping working earlier test

.Biogen and UCB's bet one's bottom dollar developing right into stage 3 astride a broken research st...

Aptadir really hopes new RNA inhibitors may turn around difficult cancers

.Italian biotech Aptadir Therapies has launched along with the assurance that its own pipe of precli...